Loading TSHA charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading TSHA comparable companies…
| TSHATaysha Gene Therapies, Inc.(opens in a new tab) | $1.52B | $0.01B | −32.3% | — | −2792.3% | 276.53× | — |
|---|---|---|---|---|---|---|---|
| ATRAAtara Biotherapeutics, Inc.(opens in a new tab) | $0.12B | $0.01B | −96.7% | — | −229.7% | 19.22× | — |
| CGONCG Oncology, Inc.(opens in a new tab) | $5.70B | $0.01B | +1030.3% | — | −4056.2% | 915.00× | — |
| FATEFate Therapeutics Inc.(opens in a new tab) | $0.25B | $0.01B | −23.4% | — | −2058.1% | 38.67× | — |
| PRMEPrime Medicine, Inc.(opens in a new tab) | $0.84B | $0.00B | +55.3% | — | — | — | — |
| Medianpeers, excl. TSHA | $0.54B | $0.01B | +16.0% | — | −2058.1% | 38.67× | — |